Nano-Terra and 3M Enter into Nano-Collaboration

In an effort to more fully realize the potential of nanotechnology fabrication in advanced materials and devices, the Nano-Terra Company today announced a multi-year development and licensing agreement with 3M. Nano-Terra is a privately-held company focused on commercializing industrial applications of nano- and micro-technologies that have been developed by Nano-Terra co-founder Dr. George Whitesides at his renowned laboratory at Harvard University.

The cooperative agreement is designed to bring to market innovative, nanotechnology-based products and solutions made possible by the groundbreaking nano-scale, molecular fabrication methods pioneered by Professor Whitesides and the scientists at Nano-Terra. The Cambridge-based company is employing the design and manipulation of molecular structures for the creation of new properties and functionalities in materials.

Carmichael Roberts, Vice Chairman and co-founder of Nano-Terra, said, “3M is an innovative, diversified technology company with a stable of well-known brands, and is a global leader in commercializing nanotechnology. We are proud they have chosen Nano-Terra as a collaborative partner with the technology and expertise to apply nano-scale fabrication to commercially viable processes and products. As a first step, we are focusing on how our expertise in soft lithography and in molecular self-assembly can support 3M’s own development work in certain application areas.”

The co-development work will be performed primarily at Nano-Terra’s lab facilities in Cambridge, with frequent input from and milestone reviews by 3M.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.